Welcome to our dedicated page for Bwx Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BWX Technologies, Inc. (NYSE: BWXT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. BWXT files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that cover financial performance, material agreements, capital structure changes and governance matters related to its nuclear-focused manufacturing and engineering business.
BWXT’s Form 8-K filings illustrate the range of topics investors can track. Recent 8-Ks have reported quarterly financial results, including revenue and segment performance for Government Operations and Commercial Operations, and have furnished earnings press releases that explain non-GAAP measures such as adjusted EBITDA, non-GAAP earnings per share and free cash flow. Other 8-Ks describe executive leadership changes, such as appointments of senior finance and legal officers, and provide details on material definitive agreements.
Filings also document capital markets transactions. In 2025, BWXT filed an 8-K describing the issuance of 0% Convertible Senior Notes due 2030 under an indenture with a trustee, including the aggregate principal amount, guarantee structure by certain domestic subsidiaries, conversion conditions, maturity date and events of default. Another 8-K discusses the planned private offering of convertible senior notes and expectations regarding a new senior secured revolving credit facility, subject to market conditions and other factors.
Through this page, users can follow BWXT’s official disclosures about its nuclear-related operations, contracts and financial condition. Stock Titan enhances access to these documents with AI-powered summaries that highlight key terms in filings such as 10-K and 10-Q reports, and can help interpret complex sections on topics like segment performance, non-GAAP metrics, convertible notes and covenant structures. The page also links to insider and governance-related information reported in current reports, giving a consolidated view of BWXT’s regulatory record.
BWX Technologies, Inc. executive Omar F. Meguid, SVP and Chief Digital Officer, reported equity transactions in company stock. On 01/05/2026, 2,931 shares of common stock were acquired at an exercise price of $0 through the vesting and settlement of previously granted restricted stock units (coded "M"). On the same date, 766 shares were disposed of at $181.85 per share (coded "F"), typically reflecting shares withheld or sold to cover taxes. Following these transactions, Meguid directly beneficially owns 4,526 shares of BWX Technologies common stock. The underlying RSU award originally vested in three equal annual installments beginning January 5, 2024.
BWX Technologies director reports new dividend equivalent rights in a Form 4 insider transaction. On 12/10/2025, the reporting person acquired 12.23 dividend equivalent rights related to existing restricted stock unit (RSU) grants, each representing the right to receive one share of BWX Technologies common stock. The filing states that the director has elected to defer receipt of the shares underlying the RSUs, and the dividend equivalent rights will be delivered proportionately with the related RSUs. Following this transaction, the director beneficially owns 312.23 dividend equivalent rights on a direct basis.
BWX Technologies director reports small derivative award tied to deferred RSUs. A company director filed a Form 4 reporting the acquisition of 5.25 dividend equivalent rights on BWX Technologies common stock on 12/10/2025. These rights accrued on three existing restricted stock unit grants for which the director has elected to defer receipt of the underlying shares. Each restricted stock unit and each dividend equivalent right represents a contingent right to receive one share of BWX Technologies common stock. After this transaction, the director beneficially owned 41.78 dividend equivalent rights related to BWX Technologies common stock, which will be delivered proportionately over time with the associated restricted stock units.
BWX Technologies, Inc. director Leland D. Melvin reported acquiring dividend equivalent rights tied to his existing deferred restricted stock units. On 12/10/2025, he received 11.42 dividend equivalent rights, each representing a contingent right to receive one share of BWXT common stock, matching four restricted stock unit grants for which he has elected to defer share receipt. These rights will be delivered to him proportionately with the related RSUs. The filing shows he now beneficially owns 204.39 dividend equivalent rights on a direct basis, with a stated price of $0 for the derivative securities.
BWX Technologies, Inc. director Kenneth J. Krieg reported an acquisition of dividend equivalent rights tied to his existing equity awards. On 12/10/2025, he received 29.22 dividend equivalent rights associated with nine restricted stock unit (RSU) grants, with each right representing a contingent claim to one share of BWXT common stock at a price of $0 per right. Following this transaction, he beneficially owned 1,392.2 derivative securities directly. The filing notes that Krieg has elected to defer receipt of the RSU shares, and the related dividend equivalent rights will be delivered proportionately when those RSUs are ultimately settled in BWXT common stock.
BWX Technologies, Inc. director James M. Jaska reported a routine equity compensation-related transaction. On 12/10/2025, he acquired 21.82 dividend equivalent rights (DERs) tied to BWXT common stock at a price of $0 per right. Each DER represents a contingent right to receive one share of BWXT common stock.
The filing states these DERs accrued on seven restricted stock unit (RSU) grants for which Jaska has elected to defer receipt of the underlying shares. The DERs will be delivered proportionately with the related RSUs. Following this transaction, he beneficially owned 1,065.53 DERs, held directly.
BWX Technologies, Inc. director reports additional stock-linked rights. On 12/10/2025, a reporting person who serves as a director of BWX Technologies, Inc. (ticker BWXT) acquired 17.69 dividend equivalent rights tied to existing restricted stock unit (RSU) awards. Each RSU and each dividend equivalent right represents a contingent right to receive one share of BWXT common stock, with no cash exercise price.
The director has elected to defer receipt of the shares underlying these RSUs, and the related dividend equivalent rights will be delivered proportionately as the deferred RSUs are settled. Following this transaction, the director beneficially owned 741.34 dividend equivalent rights on a direct basis.
BWX Technologies, Inc. director Jan A. Bertsch reported receiving additional dividend equivalent rights tied to previously granted restricted stock units as of 12/10/2025. The filing shows 32.84 dividend equivalent rights credited at a price of $0, increasing her total derivative securities beneficially owned to 2,175.51, held directly. Each restricted stock unit and dividend equivalent right represents a contingent right to receive one share of BWXT common stock, and, under her deferral election, the dividend equivalent rights will be delivered proportionately with the related restricted stock units.
BWX Technologies reported new equity awards to a senior executive. On December 1, 2025, the company granted its SVP and General Counsel restricted stock units and stock options. The awards include 801 RSUs that vest in three equal annual installments beginning December 1, 2026, and an additional 1,714 RSUs that vest in two equal annual installments beginning the same date. The filing also shows an employee stock option grant for 2,337 shares of common stock with an exercise price of $174.93 per share, vesting in three equal annual installments from December 1, 2026 and expiring on December 1, 2035. These grants are reported as directly owned by the executive.
BWX Technologies (BWXT) filed a Form 3, the initial statement of beneficial ownership for its SVP and General Counsel. The reporting person disclosed no securities beneficially owned (0) and indicated the filing was made by one reporting person. The event date is 11/04/2025. The submission includes an Exhibit 24 power of attorney and was signed by an attorney-in-fact.
FAQ
What is the current stock price of Bwx Technologies (BWXT)?
What is the market cap of Bwx Technologies (BWXT)?
